Carmine Therapeutics, headquartered in Cambridge MA, is pioneering a new class of non-viral gene therapies based on red blood cell extracellular vesicles, combined with proprietary payloads.

Biotechnology

Carmine Therapeutics

John Robblee

Özge Gürsoy-Yüzügüllü,PhD

Qin Yu

Tenzin Gocha

The board of directors at Carmine Therapeutics has a history of experience in the medical and finance industries. The board members have founded and been investors in several companies, including LogicBio Therapeutics, Voyager Therapeutics, Carcell Biopharma, and Nuevocor. They have also served as professors at Stanford University School of Medicine and Stanford University.

Board of Directors

About

Team members

Other teams at Carmine Therapeutics

Leadership Team

Founding Team